Author

Caleb Schmicker

Q2 Solutions (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:imaging· 1 Organism:mouse· 1

Frequent Co-Authors

David A. KatziD· 1 shared Jiahui XuiD· 1 shared Jiawen LiiD· 1 shared Jing Su· 1 shared Min LiiD· 1 shared Qiongqiong Hou· 1 shared Tobias Magers· 1 shared William M Bracken· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

David A. KatzORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The 11β-hydroxysteroid dehydrogenase type 1 inhibitor SPI-62 prevents morbidity in a mouse model of Cushing's syndrome

Xingyu Pan, Qiongqiong Hou, Jing Su, Jiahui Xu, Min Li, Jiawen Li, Xuerou Shi, Caleb Schmicker, Tobias Magers, William M Bracken, David A. Katz

SPI-62, an HSD-1 inhibitor, reduces GC-induced morbidity in a mouse Cushing's syndrome model by improving insulin sensitivity, reducing adiposity, and preventing skeletal myopathy.

bioRxiv · May 27, 2024 · PreprintPharmacology & Toxicology